Skip to content
DataLookout
Menu

NCT06955715

Pasteurized Donor Human Milk for HIV-Exposed Infants: A Pilot Study

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 3 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 6 words Show 7 more changesShow less
    • Primary endpoints: details revised at 2 of 2 entries
    • Trial completed
    • Final enrollment: 4 participants (planned 10)
    • Primary completion date changed from estimate of May 1, 2026 to Nov 18, 2025
    • Study completion date changed from estimate of Dec 31, 2026 to Sep 21, 2026
    • Study description revised
    • Site details revised
  2. Notable Eligibility criteria revised
    • Study description expanded, about 3 words
    v3
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Frequency of PDHM provision (#/day)
Timeframe: 8-12 week intervention period
Volume of PDHM provision (mL/day)
Timeframe: 8-12 week intervention period

Secondary (2)

Events of infant intolerance (n, %)
Caregiver-related experiences and challenges

Arms and interventions

Pasteurized Donor Human MilkExperimental

Pasteurized donor human milk sourced from the Norther Star Mother's Milk Bank (Calgary, AB, Canada)

Other: Pasteurized Donor Human Milk

Sites

1 site in 1 country

  • University of SaskatchewanSaskatoon, Saskatchewan, Canada